skip to main content

Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms, hedge funds, financial advisors and other financial institutions and investors on their most important merger, acquisitions and takeover transactions.

PRA Health Sciences to Be Acquired by ICON in $12 Billion Deal

Paul, Weiss is advising PRA Health Sciences, Inc., a leading global contract research organization, in its approximately $12 billion cash-and-stock sale to ICON plc, a global provider of outsourced drug and medical device development and commercialization services. Under the terms of the transaction, PRA shareholders will receive $80 in cash and 0.4125 shares of ICON stock per share—an approximately 30% premium to PRA’s closing price as of February 23. The deal is expected to close during the third quarter of 2021, subject to regulatory and shareholder approvals and customary closing conditions.

The Paul, Weiss team includes, among others, corporate partners Krishna Veeraraghavan, Laura Turano, Caith Kushner and counsel Suhan Shim and Mikhel Schecter; litigation partner Rick Rule and counsel Steven Herzog, Peter Jaffe and Rachel Fiorill; intellectual property partner Jonathan Ashtor; tax partner Robert Holo; antitrust counsel Marta Kelly; international trade counsel Richard Elliott; and environmental counsel William O’Brien.

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy